TR200200401T2 - PEG-IFN-a ile birlikte mikofenolat mofetil - Google Patents
PEG-IFN-a ile birlikte mikofenolat mofetilInfo
- Publication number
- TR200200401T2 TR200200401T2 TR2002/00401T TR200200401T TR200200401T2 TR 200200401 T2 TR200200401 T2 TR 200200401T2 TR 2002/00401 T TR2002/00401 T TR 2002/00401T TR 200200401 T TR200200401 T TR 200200401T TR 200200401 T2 TR200200401 T2 TR 200200401T2
- Authority
- TR
- Turkey
- Prior art keywords
- ifn
- peg
- mycophenolate mofetil
- treatment
- therapeutically effective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99115950 | 1999-08-13 | ||
US18790700P | 2000-03-08 | 2000-03-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200200401T2 true TR200200401T2 (tr) | 2002-06-21 |
Family
ID=29762814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2002/00401T TR200200401T2 (tr) | 1999-08-13 | 2000-08-08 | PEG-IFN-a ile birlikte mikofenolat mofetil |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1220683A2 (fr) |
JP (1) | JP2003507339A (fr) |
CN (1) | CN1368887A (fr) |
AU (1) | AU7408200A (fr) |
BR (1) | BR0013252A (fr) |
CA (1) | CA2380653A1 (fr) |
HU (1) | HUP0202525A3 (fr) |
MX (1) | MXPA02001296A (fr) |
PE (1) | PE20010490A1 (fr) |
PL (1) | PL357367A1 (fr) |
RU (1) | RU2002105485A (fr) |
TR (1) | TR200200401T2 (fr) |
WO (1) | WO2001012214A2 (fr) |
ZA (1) | ZA200200280B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0307553D0 (en) * | 2003-04-01 | 2003-05-07 | Novartis Ag | Organic compounds |
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
PL1719773T3 (pl) | 2004-02-24 | 2009-08-31 | Japan Tobacco Inc | Skondensowane związki heterotetracykliczne i ich zastosowanie jako inhibitora polimerazy HCV |
ES2349472T3 (es) * | 2004-08-12 | 2011-01-03 | Schering Corporation | Formulación estable de interferón pegilado. |
US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
US8017612B2 (en) | 2006-04-18 | 2011-09-13 | Japan Tobacco Inc. | Piperazine compound and use thereof as a HCV polymerase inhibitor |
WO2010110503A1 (fr) * | 2009-03-27 | 2010-09-30 | 주식회사 중외제약 | Protéine fusionnée d'interféron-α (ifn-α) comprenant l'ifn-α et un peptide de transduction cytoplasmique (ctp) |
ES2529143B1 (es) | 2011-10-21 | 2015-10-26 | Abbvie Inc. | Combinación de al menos dos agentes antivirales de acción directa, ribavirina pero no interferón para uso de tratamiento del vhc |
US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
PT107925A (pt) | 2011-10-21 | 2014-12-03 | Abbvie Inc | Tratamento de combinação de daa (eg. com abt-072 ou abt-333) para utilização no tratamento de hcv |
NZ730924A (en) * | 2014-11-06 | 2022-04-29 | Pharmaessentia Corp | Dosage regimen for pegylated interferon |
CN109689063A (zh) | 2016-04-28 | 2019-04-26 | 埃默里大学 | 含有炔烃的核苷酸和核苷治疗组合物及其相关用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5908621A (en) * | 1995-11-02 | 1999-06-01 | Schering Corporation | Polyethylene glycol modified interferon therapy |
MY125300A (en) * | 1999-02-26 | 2006-07-31 | Inst Of Molecular And Cell Biology | Synergistic combination for treatment of viral-mediated diseases |
-
2000
- 2000-08-08 PE PE2000000804A patent/PE20010490A1/es not_active Application Discontinuation
- 2000-08-08 EP EP00962297A patent/EP1220683A2/fr not_active Withdrawn
- 2000-08-08 JP JP2001516559A patent/JP2003507339A/ja active Pending
- 2000-08-08 RU RU2002105485/15A patent/RU2002105485A/ru not_active Application Discontinuation
- 2000-08-08 AU AU74082/00A patent/AU7408200A/en not_active Abandoned
- 2000-08-08 HU HU0202525A patent/HUP0202525A3/hu unknown
- 2000-08-08 BR BR0013252-7A patent/BR0013252A/pt not_active IP Right Cessation
- 2000-08-08 CA CA002380653A patent/CA2380653A1/fr not_active Abandoned
- 2000-08-08 PL PL00357367A patent/PL357367A1/xx not_active Application Discontinuation
- 2000-08-08 CN CN00811397A patent/CN1368887A/zh active Pending
- 2000-08-08 WO PCT/EP2000/007666 patent/WO2001012214A2/fr not_active Application Discontinuation
- 2000-08-08 TR TR2002/00401T patent/TR200200401T2/xx unknown
- 2000-08-08 MX MXPA02001296A patent/MXPA02001296A/es unknown
-
2002
- 2002-01-11 ZA ZA200200280A patent/ZA200200280B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0202525A3 (en) | 2003-11-28 |
RU2002105485A (ru) | 2004-01-27 |
JP2003507339A (ja) | 2003-02-25 |
HUP0202525A2 (hu) | 2002-11-28 |
ZA200200280B (en) | 2003-04-11 |
CA2380653A1 (fr) | 2001-02-22 |
PE20010490A1 (es) | 2001-04-27 |
PL357367A1 (en) | 2004-07-26 |
AU7408200A (en) | 2001-03-13 |
BR0013252A (pt) | 2002-04-16 |
EP1220683A2 (fr) | 2002-07-10 |
MXPA02001296A (es) | 2002-07-22 |
WO2001012214A3 (fr) | 2001-10-04 |
CN1368887A (zh) | 2002-09-11 |
WO2001012214A2 (fr) | 2001-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2003119460A (ru) | Применение пэг-интерферона-а(пэг-inf-а) и рибавирина для лечения хронического гепатита с | |
TR200200401T2 (tr) | PEG-IFN-a ile birlikte mikofenolat mofetil | |
DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
DK275488D0 (da) | Indolonderivater | |
BRPI0108977B8 (pt) | compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo | |
ES2169762T3 (es) | Liberacion continua de peptidos a partir de composiciones farmaceuticas. | |
KR920700200A (ko) | 19-노르-비타민 d 화합물 | |
ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
IL112667A0 (en) | 6-substituted derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them | |
BR9916860A (pt) | Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma | |
CA2302568A1 (fr) | Procede, compositions et trousses servant a augmenter la biodisponibilite orale d'agents pharmaceutiques | |
TR200101633T2 (tr) | Farmasötik bileşim | |
KR970025615A (ko) | 암 전이 억제제 | |
ATE257704T1 (de) | Pharmazeutische zusammensetzungen enthaltend norastemizol. | |
NO20003313D0 (no) | Terapeutiske midler | |
RU2004137823A (ru) | Терапевтическое средство против гиперкальциемического криза | |
AR012731A1 (es) | Uso de un derivado de taxano para la preparacion de una composicion farmaceutica , uso de un agente mejorador de la biodicponibilidad de dicho derivado forma de dosificacion oral y conjunto afrmaceutico que lo comprende y metodo para formar a un agente activo biodisponible. | |
KR830002510A (ko) | 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물 | |
ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
JP2002544227A5 (fr) | ||
RU2004131214A (ru) | Способы лечения когнитивных расстройств | |
AR025549A1 (es) | Mofetil micofelonato en asociacion con peg-ifn-alfa | |
KR890012942A (ko) | 5-치환된 오르니틴 유도체 | |
RU2006101061A (ru) | Азенапин для лечения шизофрении у пациентов с избыточной массой тела или предрасположенностью к избыточной массе тела | |
YU9302A (sh) | Mikofenolat mofetil u kombinaciji sa peg-ifn-alfa |